Evidence map›Paper›PMID 11313938›Full record

ArticleOncogene2001

Activation of the I kappa B alpha kinase (IKK) complex by double-stranded RNA-binding defective and catalytic inactive mutants of the interferon-inducible protein kinase PKR.

T Ishii, H Kwon, J Hiscott, G Mosialos, A E Koromilas

Abstract read
PubMed Publisher
In one paragraph

Article in Oncogene, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 64 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research · 2021
    Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Ubiquitination-mediated regulation of interferon responses.Growth factors (Chur, Switzerland) · 2012
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

T IshiiDepartment of Microbiology and Immunology, McGill University, Montreal, Quebec, Canada.
H Kwon
J Hiscott
G Mosialos
A E Koromilas
McGill University · CAAlexander Fleming Biomedical Sciences Research Center · GR

Funding

SIGNAL TRANSDUCTION BY THE EBV TRANSFORMING PROTEIN LMP1R29CA071705 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI MOSIALOS, GEORGE · 1996 to 1999
–
NCI NIH HHS CA71705
6 · The paper itself

Abstract

The interferon (IFN)-inducible double stranded (ds) RNA-activated protein kinase PKR plays an important role in protein synthesis by modulating the phosphorylation of the alpha-subunit of eukaryotic initiation fact 2 (eIF-2 alpha). In addition to translational control, PKR has been implicated in several signaling pathways leading to gene transcription. For example, PKR induces I kappa B alpha kinase (IKK) activity and I kappa B alpha phosphorylation leading to the induction of NF-kappa B-mediated gene transcription. Recent findings suggested that NF-kappa B activation by PKR does not require the catalytic activity of the kinase. Here, we provide novel evidence that induction of IKK and NF-kappa B activities proceeds independently of the dsRNA-binding properties of PKR and also verify the kinase-free role of PKR in this process. We also show that the effects of PKR mutants on IKK and NF-kappa B activation are independent of cell transformation but are dependent on the amount of the mutant PKR proteins expressed in cells. These data strongly support an indirect role of PKR in I kappa B alpha phosphorylation by modulating IKK activity through pathways that do not utilize the enzymatic and dsRNA-binding properties of PKR.

Indexed as

3T3 CellsAnimalsCatalysisCell Transformation, NeoplasticDNAeIF-2 KinaseEnzyme ActivationHumansI-kappa B KinaseInterferonsMiceMitogen-Activated Protein Kinase 8Mitogen-Activated Protein KinasesNF-kappa BPhosphorylationProtein Serine-Threonine KinasesCHUK protein, humanChuk protein, mouseDNAeIF-2 KinaseI-kappa B KinaseIKBKB protein, humanIkbkb protein, mouseIKBKE protein, humanIkbke protein, mouseInterferonsMitogen-Activated Protein Kinase 8Mitogen-Activated Protein KinasesNF-kappa BProtein Serine-Threonine KinasesRNA, Double-Stranded

Identifiers

PMID11313938
OpenAlexW2093490741

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.